Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin

Abstract

β-catenin is a multifunctional protein involved in both cadherin-mediated adhesion and the wnt signaling cascade. Mutations in exon 3 of β-catenin have been identified in many cancers. In addition to disruption of key serine and threonine residues, mutations are frequently reported in other residues in exon 3 that are not kinase substrates. The most frequently mutated nonserine/threonine residues are D32 and G34. Since D32 and G34 are part of the ubiquitination destruction motif, DSGΦXS, we hypothesize that this motif may contribute to disruption of β-catenin homeostasis and lead to cellular transformation. We demonstrate that the mutants D32A and G34A exhibit no change in phosphorylation by GSK3β, but display reduced ubiquitination compared to wild-type and S33A mutant β-catenin. To assess the functional implications of these mutations, we created stable MDCK cell lines expressing these constructs. We found that stable cell lines harboring D32A-mutated β-catenin were highly transformed, while S33A and G34 demonstrated only weak transforming properties in our assays. Despite altered ubiquitination status and increased transformation, the D32A mutant cell line does not display transcriptional activation of standard target genes. Therefore, D32A mutation may mediate transformation by an alternative β-catenin-mediated signaling pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Aberle H, Bauer A, Stappert J, Kispert A and Kemler R . (1997). EMBO J., 16, 3797–3804.

  • Al-Fageeh M, Li Q, Mohaiza Dashwood W, Myzak MC and Dashwood RH . (2004). Oncogene, 23, 4839–4846.

  • Besnard-Guerin C, Belaidouni N, Lassot I, Segeral E, Jobart A, Marchal C and Benarous R . (2004). J. Biol. Chem., 279, 788–795.

  • Guardavaccaro D, Kudo Y, Boulaire J, Barchi M, Busino L, Donzelli M, Margottin-Goguet F, Jackson PK, Yamasaki L and Pagano M . (2003). Dev. Cell, 4, 799–812.

  • Hattori K, Hatakeyama S, Shirane M, Matsumoto M and Nakayama K . (1999). J. Biol. Chem., 274, 29641–29647.

  • Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ . (2000). J. Cell Biol., 149, 1309–1323.

  • Liu J, Stevens J, Rote CA, Yost HJ, Hu Y, Neufeld KL, White RL and Matsunami N . (2001). Mol. Cell, 7, 927–936.

  • Lustig B and Behrens J . (2003). J. Cancer Res. Clin. Oncol., 129, 199–221.

  • Matsuzawa SI and Reed JC . (2001). Mol. Cell, 7, 915–926.

  • Orford K, Crockett C, Jensen JP, Weissman AM and Byers SW . (1997). J. Biol. Chem., 272, 24735–24738.

  • Polakis P . (2000). Genes Dev., 14, 1837–1851.

  • Polakis P . (2002). Curr. Biol., 12, R499–R501.

  • Provost E, Yamamoto Y, Lizardi I, Stern J, D'Aquila TG, Gaynor RB and Rimm DL . (2003). J. Biol. Chem., 278, 31781–31789.

  • Wu G, Xu G, Schulman BA, Jeffrey PD, Harper JW and Pavletich NP . (2003). Mol. Cell, 11, 1445–1456.

  • Zou JX, Liu Y, Pasquale EB and Ruoslahti E . (2002). J. Biol. Chem., 277, 1824–1827.

Download references

Acknowledgements

We thank Hui Zhang, Yale University, Department of Genetics, for providing the HA-Ub construct, Sheng-Cai Lin for the HA-CKIIalpha construct, WJ Harper, Baylor College of Medicine, for the HA-β-TrCP construct, Joseph Madri, Yale University, Department of Pathology, for the use of his Coulter Counter and Addie Tucker for her help with the collagen I assay. Finally, we thank Michael Wolfgang for discussion of some of the experiments and assistance with the figures. Dr Rimm is supported by a grant from the Patrick and Catherine Weldon Donaghue Foundation for Medical Research and grants from the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David L Rimm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Provost, E., McCabe, A., Stern, J. et al. Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin. Oncogene 24, 2667–2676 (2005). https://doi.org/10.1038/sj.onc.1208346

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208346

Keywords

This article is cited by

Search

Quick links